# Alphamab Oncology

> Alphamab Oncology is a VC fund in Suzhou backing Medical and 3D Technology. See 1 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Suzhou, China
- Total investments: 1
- Last investment: Mar 2020
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/%E6%B1%9F%E8%8B%8F%E5%BA%B7%E5%AE%81%E6%9D%B0%E7%91%9E%E7%94%9F%E7%89%A9%E5%88%B6%E8%8D%AF%E6%9C%89%E9%99%90%E5%85%AC%E5%8F%B8%EF%BC%88alphamabonc%EF%BC%89/
- Website: http://www.alphamabonc.com

Alphamab Oncology is a clinical-stage biopharmaceutical company dedicated to the discovery, development manufacturing and commercialization of world-class innovative therapeutics for cancer treatment with multiple in-house proprietary platforms in bispecifics, protein engineering and antibody screening, Alphamab Oncology has built a robust pipelinein oncology/ immunology, and they are striving to develop next-generation or best-in-class medicines to address unmet medical needs globally.

## Contacts

5 contacts available for Alphamab Oncology. Shizune tracks 6 team members at Alphamab Oncology. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/alphamab-oncology?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 1 | 100% |
| 3D Technology | 1 | 100% |
| Biotechnology | 1 | 100% |
| Medical Device | 1 | 100% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Johannes Nippgen | Chief Medical Officer | 0 | — |
| Kenneth Kwong | Acting Chief Medical Officer | 0 | — |
| Terry Shuai | Chief Financial Officer | 0 | — |
| Weihao Xu | Chief Financial Officer | 0 | — |
| Weihao Xu | Chief Financial Officer | 0 | — |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Sidi Diagnostics | Sidi Diagnostics is a medical technology company that focuses on new molecular diagnostic technologies. | $40M | Venture - Series Unknown | Mar 01, 2020 |  |

1 of 1 investments shown.

## Co-investors
- [China Minsheng Investment Group](https://shizune.co/investors/profile/china-minsheng-investment-group) — VC Fund, 1 deal together
- [CICC Capital](https://shizune.co/investors/profile/cicc-capital) — VC Fund, 1 deal together
- Jemincare — VC Fund, 1 deal together
- [Lucion](https://shizune.co/investors/profile/lucion) — VC Fund, 1 deal together
- [Qingsong Capital](https://shizune.co/investors/profile/qingsong-capital) — VC Fund, 1 deal together
- Sangel Capital — VC Fund, 1 deal together

## Similar investors

### Similar stage
- [Bossa Invest](https://shizune.co/investors/profile/bossanova-investimentos) — VC Fund
- [Almi Invest](https://shizune.co/investors/profile/almi-invest) — VC Fund
- [Korea Credit Guarantee Fund](https://shizune.co/investors/profile/korea-credit-guarantee-fund) — VC Fund

## FAQ

### What does Alphamab Oncology invest in?

Alphamab Oncology invests primarily in Medical, 3D Technology and Biotechnology startups, most often at Venture - Series Unknown stage. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact Alphamab Oncology?

Public channels for Alphamab Oncology include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at Alphamab Oncology?

The team at Alphamab Oncology includes Johannes Nippgen (Chief Medical Officer), Kenneth Kwong (Acting Chief Medical Officer) and Terry Shuai (Chief Financial Officer), among 6 team members tracked by Shizune. The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co